ACELYRIN $621 million IPO
The stock is listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Enovix $162.5 million convertible senior notes and capped call transactions
The 3.00% convertible notes are due 2028
Revolution Medicines $345 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Tenaya Therapeutics $75 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Natera $400 million follow-on offering
The shares are listed on Nasdaq
Elon Musk $13.2 billion Twitter acquisition financing
We advised the agent, joint lead arrangers and initial lenders on the financing
IDEAYA Biosciences $92 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Tenaya Therapeutics $75 million at-the-market offering
The common stock is listed on the Nasdaq Global Select Market
RxSight $50 million at-the-market offering
The stock is listed on the Nasdaq Global Market
Cryoport $403 million notes offering and concurrent $249 million stock offering
The company issued 0.75% convertible senior notes due 2026 and sold shares in a registered direct offering